Metraipolis › archive › dc_8d64ce2dbf71

Therapeutic drug monitoring of selumetinib in pediatrics: a combined LC-MS/MS and LC-HRMS approach — Europe PMC PMID:40900834

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40900834
DOI: 10.3389/fphar.2025.1649335
License (as archived): solo-consultazione
Archived: 2026-11-10T12:40:05.677Z
SHA-256 of the archived text: 876ce9527bf283da98c44e61db6b50987030a33ebb1a37d4780f8149e6fab779
Stable URL of this page: https://metraipolis.com/documento/dc_8d64ce2dbf71

How to cite

Therapeutic drug monitoring of selumetinib in pediatrics: a combined LC-MS/MS and LC-HRMS approach — Europe PMC PMID:40900834 — Europe PMC (en), https://europepmc.org/article/MED/40900834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d64ce2dbf71 (Metraipolis archive dc_8d64ce2dbf71, sha256 876ce9527bf283da98c44e61db6b50987030a33ebb1a37d4780f8149e6fab779)

BibTeX

@misc{dc8d64ce2dbf71,
  title = {Therapeutic drug monitoring of selumetinib in pediatrics: a combined LC-MS/MS and LC-HRMS approach — Europe PMC PMID:40900834},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40900834},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d64ce2dbf71; sha256 876ce9527bf283da98c44e61db6b50987030a33ebb1a37d4780f8149e6fab779},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40900834. Agents can read the archived copy with the MCP tool read_document.